Your browser doesn't support javascript.
loading
Macrophage migration inhibitory factor promotes tumor aggressiveness of esophageal squamous cell carcinoma via activation of Akt and inactivation of GSK3ß.
Liu, Rui-Min; Sun, Dan-Ni; Jiao, Ye-Lin; Wang, Pan; Zhang, Juan; Wang, Ming; Ma, Jin; Sun, Man; Gu, Bian-Li; Chen, Pan; Liu, Ke; Ma, Heng; Gao, She-Gan; Ma, Yuan-Fang; Qi, Yi-Jun.
Afiliación
  • Liu RM; Joint National Laboratory for Antibody Drug Engineering, Medical College of Henan University, Kaifeng, Henan, 475004, PR China.
  • Sun DN; Joint National Laboratory for Antibody Drug Engineering, Medical College of Henan University, Kaifeng, Henan, 475004, PR China.
  • Jiao YL; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, PR China.
  • Wang P; First Teaching Hospital, Tianjin University of Traditional Chinese Medicine, Tianjin, 300193, PR China.
  • Zhang J; Joint National Laboratory for Antibody Drug Engineering, Medical College of Henan University, Kaifeng, Henan, 475004, PR China.
  • Wang M; Joint National Laboratory for Antibody Drug Engineering, Medical College of Henan University, Kaifeng, Henan, 475004, PR China.
  • Ma J; Joint National Laboratory for Antibody Drug Engineering, Medical College of Henan University, Kaifeng, Henan, 475004, PR China.
  • Sun M; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, PR China.
  • Gu BL; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, PR China.
  • Chen P; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, PR China.
  • Liu K; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, PR China.
  • Ma H; Respiratory Department, Xinmi Hospital of Traditional Chinese Medicine, Xinmi, 452370, PR China.
  • Gao SG; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, PR China.
  • Ma YF; Joint National Laboratory for Antibody Drug Engineering, Medical College of Henan University, Kaifeng, Henan, 475004, PR China. Electronic address: mayf@henu.edu.cn.
  • Qi YJ; Henan Key Laboratory of Cancer Epigenetics, Cancer Hospital, The First Affiliated Hospital, College of Clinical Medicine, Medical College of Henan University of Science and Technology, Luoyang, 471003, PR China. Electronic address: qiyijun@hotmail.com.
Cancer Lett ; 412: 289-296, 2018 01 01.
Article en En | MEDLINE | ID: mdl-29079416
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Factores Inhibidores de la Migración de Macrófagos / Proteínas Proto-Oncogénicas c-akt / Glucógeno Sintasa Quinasa 3 beta Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Lett Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas / Factores Inhibidores de la Migración de Macrófagos / Proteínas Proto-Oncogénicas c-akt / Glucógeno Sintasa Quinasa 3 beta Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancer Lett Año: 2018 Tipo del documento: Article